Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triferic and Heparin Co-administration in Hemodialysis
NCT04042324Phase 2Completed
- Sponsor
- Rockwell Medical
- Start
- Sep 2019
- Primary completion
- Jan 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of ferric pyrophosphate in anemia of chronic kidney disease (CKD-A), sponsored by Rockwell Medical. Started Sep 2019; status: completed.
02
Drugs
ferric pyrophosphate
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT04042324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04042324.